Heron Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Anika Therapeutics 0 0 Mar/2025
Eisai 3.28 0.07 Mar/2026
Emergent BioSolutions 0 0 Mar/2025
Esperion Therapeutics 0 0 Mar/2025
GlaxoSmithKline 0.82 3.75 Mar/2026
Heron Therapeutics 0 0 Mar/2025
Merck 2.76 0.36 Mar/2026
Nektar Therapeutics 0 0 Mar/2025
Omeros 0 0 Mar/2025
Regeneron Pharmaceuticals 0.46 0.01 Mar/2026
Roche Holding 2.96 0.8 Dec/2025
Sangamo BioSciences 0 0 Mar/2025
Surmodics 0 0 Mar/2025